Published in J Virol on June 01, 1996
Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1. J Virol (2000) 2.95
Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins. Microbiol Mol Biol Rev (2001) 2.06
Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments. J Virol (2000) 1.72
Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor. J Virol (1997) 1.47
Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: role of the V1/V2 domains. J Virol (2000) 1.14
HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding. Retrovirology (2004) 1.12
Receptor co-operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding. EMBO J (1997) 1.07
Induction of syncytia by neuropathogenic murine leukemia viruses depends on receptor density, host cell determinants, and the intrinsic fusion potential of envelope protein. J Virol (1999) 1.04
Sodium-dependent myo-inositol transporter 1 is a cellular receptor for Mus cervicolor M813 murine leukemia virus. J Virol (2003) 1.01
Intracellular complexes of viral spike and cellular receptor accumulate during cytopathic murine coronavirus infections. J Virol (1998) 0.98
Analysis of receptor usage by ecotropic murine retroviruses, using green fluorescent protein-tagged cationic amino acid transporters. J Virol (1999) 0.90
Linkage of reduced receptor affinity and superinfection to pathogenesis of TR1.3 murine leukemia virus. J Virol (2006) 0.86
Pit2 assemblies at the cell surface are modulated by extracellular inorganic phosphate concentration. J Virol (2002) 0.86
Genetic and biochemical analyses of receptor and cofactor determinants for T-cell-tropic feline leukemia virus infection. J Virol (2002) 0.83
Library screening and receptor-directed targeting of gammaretroviral vectors. Future Microbiol (2013) 0.79
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell (1983) 25.46
Physics of chemoreception. Biophys J (1977) 15.69
The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature (1995) 12.25
Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science (1982) 10.61
Virus entry into animal cells. Adv Virus Res (1989) 7.78
Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J Virol (1988) 6.76
Viral and cellular membrane fusion proteins. Annu Rev Physiol (1990) 6.13
Transport of cationic amino acids by the mouse ecotropic retrovirus receptor. Nature (1991) 5.40
Mixed culture cytopathogenicity: a new test for growth of murine leukemia viruses in tissue culture. Proc Natl Acad Sci U S A (1969) 5.06
Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter. Nature (1991) 4.84
Transformation of mammalian cells by avian myelocytomatosis virus and avian erythroblastosis virus. Virology (1979) 4.66
Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci U S A (1994) 4.07
The adsorption of coliphage lambda to its host: effect of variations in the surface density of receptor and in phage-receptor affinity. J Mol Biol (1976) 3.75
The pH independence of mammalian retrovirus infection. J Gen Virol (1990) 3.68
Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J Virol (1994) 3.59
HIV requires multiple gp120 molecules for CD4-mediated infection. Nature (1990) 3.37
Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells. J Virol (1990) 3.07
pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry. J Virol (1994) 2.87
Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1. J Virol (1994) 2.51
Synthesis and glycosylation of polyprotein precursors to the internal core proteins of Friend murine leukemia virus. J Virol (1977) 2.26
Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons. J Virol (1992) 2.15
Plasma membrane receptors for ecotropic murine retroviruses require a limiting accessory factor. J Virol (1991) 2.05
Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1. J Virol (1995) 1.81
Ping-pong amplification of a retroviral vector achieves high-level gene expression: human growth hormone production. J Virol (1990) 1.78
Cofactor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line. J Virol (1993) 1.71
The requirements for viral entry differ from those for virally induced syncytium formation in NIH 3T3/DTras cells exposed to Moloney murine leukemia virus. J Virol (1992) 1.58
Ecotropic murine leukemia virus-induced fusion of murine cells. J Virol (1986) 1.56
Mouse mammary tumor virus can mediate cell fusion at reduced pH. Virology (1984) 1.56
The envelope glycoprotein of an amphotropic murine retrovirus binds specifically to the cellular receptor/phosphate transporter of susceptible species. J Virol (1995) 1.43
Effects of ecotropic murine retroviruses on the dual-function cell surface receptor/basic amino acid transporter. J Biol Chem (1992) 1.27
A domain of murine retrovirus surface protein gp70 mediates cell fusion, as shown in a novel SC-1 cell fusion system. J Virol (1994) 1.25
The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis. Proc Natl Acad Sci U S A (1992) 1.24
Different requirements for membrane fusion mediated by the envelopes of human immunodeficiency virus types 1 and 2. J Virol (1993) 1.19
CD4 activation of HIV fusion. Int J Cell Cloning (1992) 1.08
Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins. J Virol (1995) 1.08
Human immunodeficiency virus type 1 entry into T cells: more-rapid escape from an anti-V3 loop than from an antireceptor antibody. J Virol (1992) 1.04
Induction of syncytia by simian sarcoma virus type I (SSV-I/SSAV-I) in several human transformed cell lines. Exp Cell Biol (1980) 0.82
Transformation of rat fibroblasts and formation of virus-induced syncytia. Nature (1980) 0.79
Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol (1998) 10.94
NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin,. Proc Natl Acad Sci U S A (1975) 9.15
Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter. Nature (1991) 4.84
Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci U S A (1994) 4.07
Structure-activity relationships of an exotoxin of Pseudomonas aeruginosa. Infect Immun (1977) 3.63
Unexpectedly large size of globin messenger ribonucleic acid. Proc Natl Acad Sci U S A (1971) 3.56
Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J Virol (1997) 3.44
Evidence for a glycoprotein "signal" involved in transport between subcellular organelles. Two membrane glycoproteins encoded by murine leukemia virus reach the cell surface at different rates. J Biol Chem (1982) 3.24
Mechanism of action of Pseudomonas aeruginosa exotoxin Aiadenosine diphosphate-ribosylation of mammalian elongation factor 2 in vitro and in vivo. Infect Immun (1977) 3.17
CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. J Virol (1997) 3.04
Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1. J Virol (2000) 2.95
An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J Virol (1998) 2.73
Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses. Proc Natl Acad Sci U S A (1999) 2.62
Molecular biology of Friend viral erythroleukemia. Curr Top Microbiol Immunol (1989) 2.52
Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1. J Virol (1994) 2.51
Improved methods for purification and assay of eukaryotic messenger ribonucleic acids and ribosomes. Quantitative analysis of their interaction in a fractionated reticulocyte cell-free system. J Biol Chem (1975) 2.30
Synthesis and glycosylation of polyprotein precursors to the internal core proteins of Friend murine leukemia virus. J Virol (1977) 2.26
Isotopic labeling and analysis of phosphoproteins from mammalian ribosomes. Methods Enzymol (1974) 2.19
Plasma membrane receptors for ecotropic murine retroviruses require a limiting accessory factor. J Virol (1991) 2.05
Overcoming interference to retroviral superinfection results in amplified expression and transmission of cloned genes. Proc Natl Acad Sci U S A (1988) 2.02
Glycoprotein encoded by the Friend spleen focus-forming virus. J Virol (1979) 1.89
Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis. Mol Cell Biol (1991) 1.81
Ping-pong amplification of a retroviral vector achieves high-level gene expression: human growth hormone production. J Virol (1990) 1.78
Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses. J Virol (1997) 1.77
Gene selection in hemoglobin and in antibody-synthesizing cells. Science (1972) 1.76
The membrane glycoprotein of Friend spleen focus-forming virus: evidence that the cell surface component is required for pathogenesis and that it binds to a receptor. J Virol (1987) 1.67
Identification and characterization of a widely expressed phosphate transporter/retrovirus receptor family. Kidney Int (1996) 1.66
The Sfpi-1 proviral integration site of Friend erythroleukemia encodes the ets-related transcription factor Pu.1. J Virol (1991) 1.58
A sodium-dependent neutral-amino-acid transporter mediates infections of feline and baboon endogenous retroviruses and simian type D retroviruses. J Virol (1999) 1.58
Phosphorylation of ribosomal proteins in rabbit reticulocytes. Characterization and regulatory aspects. Biochemistry (1970) 1.56
Polymorphisms of the cell surface receptor control mouse susceptibilities to xenotropic and polytropic leukemia viruses. J Virol (1999) 1.55
Competition between globin messenger ribonucleic acids for a discriminating initiation factor. J Biol Chem (1977) 1.51
A putative cell surface receptor for anemia-inducing feline leukemia virus subgroup C is a member of a transporter superfamily. J Virol (1999) 1.48
Loss of leukemogenicity caused by mutations in the membrane glycoprotein structural gene of Friend spleen focus-forming virus. Proc Natl Acad Sci U S A (1983) 1.47
Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor. J Virol (1997) 1.47
Plasma membrane glycoproteins encoded by cloned Rauscher and Friend spleen focus-forming viruses. J Virol (1980) 1.46
Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains. J Virol (1997) 1.44
Phosphorylation of ribosomal proteins in rabbit reticulocytes. A cell-free system with ribosomal protein kinase activity. Biochemistry (1971) 1.43
The envelope glycoprotein of an amphotropic murine retrovirus binds specifically to the cellular receptor/phosphate transporter of susceptible species. J Virol (1995) 1.43
Cell surface receptors for gammaretroviruses. Curr Top Microbiol Immunol (2003) 1.42
Role of the PU.1 transcription factor in controlling differentiation of Friend erythroleukemia cells. Mol Cell Biol (1992) 1.41
Molecular cloning of biologically active Rauscher spleen focus-forming virus and the sequences of its env gene and long terminal repeat. J Virol (1984) 1.38
A murine leukemia virus mutant with a temperature-sensitive defect in membrane glycoprotein synthesis. Cell (1979) 1.34
Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways. J Biol Chem (1995) 1.34
Synthesis of erythrocyte-specific proteins in cultured friend leukemia cells. Cell (1975) 1.33
Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene. Proc Natl Acad Sci U S A (1990) 1.33
Constitutive expression of steel factor gene by human stromal cells. Blood (1993) 1.33
A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1. J Biol Chem (1999) 1.28
Disulfide bonding controls the processing of retroviral envelope glycoproteins. J Biol Chem (1991) 1.27
Effects of ecotropic murine retroviruses on the dual-function cell surface receptor/basic amino acid transporter. J Biol Chem (1992) 1.27
Role of a membrane glycoprotein in Friend virus-induced erythroleukemia: studies of mutant and revertant viruses. Virology (1985) 1.25
Genetic and sialylation sources of heterogeneity of the murine leukemia virus membrane envelope glycoproteins gp69/71. J Biol Chem (1979) 1.24
A common site for immortalizing proviral integrations in Friend erythroleukemia: molecular cloning and characterization. J Virol (1989) 1.23
Heterogeneous metabolism and subcellular localization of a potentially leukemogenic membrane glycoprotein encoded by Friend erythroleukemia virus. Isolation of viral and cellular processing mutants. J Biol Chem (1982) 1.22
Potentiation of hemoglobin messenger ribonucleic acid. A step in protein synthesis initiation involving interaction of messenger with 18 S ribosomal ribonucleic acid. J Biol Chem (1975) 1.20
The Ets-related transcription factor PU.1 immortalizes erythroblasts. Mol Cell Biol (1993) 1.20
Glycosylation and intracellular transport of membrane glycoproteins encoded by murine leukemia viruses. Inhibition by amino acid analogues and by tunicamycin. J Biol Chem (1982) 1.15
Host-range control of a retroviral disease: Friend erythroleukemia. Trends Microbiol (1995) 1.13
Changes in RNA and protein metabolism preceding onset of hemoglobin synthesis in cultured Friend leukemia cells. Dev Biol (1976) 1.12
A tagged helper-free Friend virus causes clonal erythroblast immortality by specific proviral integration in the cellular genome. J Virol (1988) 1.11
The ribosomal subunit--polyribosome cycle in protein synthesis of embryonic skeletal muscle. Biochemistry (1969) 1.08
Relationship of Friend murine leukemia virus production to growth and hemoglobin synthesis in cultured erythroleukemia cells. J Virol (1976) 1.08
Cell surface site for mitogenic interaction of erythropoietin receptors with the membrane glycoprotein encoded by Friend erythroleukemia virus. J Biol Chem (1993) 1.07
Reduced leukemogenicity caused by mutations in the membrane glycoprotein gene of Rauscher spleen focus-forming virus. J Virol (1984) 1.07
Immunoselection of mutants deficient in cell surface glycoproteins encoded by murine erythroleukemia viruses. Proc Natl Acad Sci U S A (1980) 1.05
Critical role of enhanced CD4 affinity in laboratory adaptation of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (2000) 1.05
Sodium-dependent neutral amino acid transporter type 1 is an auxiliary receptor for baboon endogenous retrovirus. J Virol (2000) 1.04
Roles of helper and defective retroviral genomes in murine erythroleukemia: studies of spleen focus-forming virus in the absence of helper. J Virol (1985) 1.04
Expression of the silent hemoglobin gene in sheep. Studies of the globin messenger ribonucleic acids. J Biol Chem (1972) 1.03
A weakly pathogenic Rauscher spleen focus-forming virus mutant that lacks the carboxyl-terminal membrane anchor of its envelope glycoprotein. J Virol (1985) 1.02
Control of cationic amino acid transport and retroviral receptor functions in a membrane protein family. J Biol Chem (1994) 1.02
Cellular and viral specificities of human immunodeficiency virus type 1 vif protein. J Virol (2000) 1.02
A comprehensive approach to mapping the interacting surfaces of murine amphotropic and feline subgroup B leukemia viruses with their cell surface receptors. J Virol (2000) 1.01
Roles of CD4 and coreceptors in binding, endocytosis, and proteolysis of gp120 envelope glycoproteins derived from human immunodeficiency virus type 1. J Biol Chem (1999) 1.01
Effect of cyclic adenosine 3':5'-monophosphate on ribosomal protein phosphorylation in reticulocytes. J Biol Chem (1974) 1.01
Mutant cells that abnormally process plasma membrane glycoproteins encoded by murine leukemia virus. Cell (1981) 1.01
The switch from fetal to adult hemoglobin in humans: evidence suggesting a role for gamma-beta gene linkage. Ann N Y Acad Sci (1974) 0.98
Cell surface receptors for murine leukemia viruses: two assays and their implications. Virology (1985) 0.97
Role of a membrane glycoprotein in Friend virus erythroleukemia: nucleotide sequences of nonleukemogenic mutant and spontaneous revertant viruses. J Virol (1986) 0.97
Splenic accumulation of interleukin-3-dependent hematopoietic cells in Friend erythroleukemia. J Virol (1989) 0.97
Synthesis of chicken hemoglobins during erythrocyte differentiation. Biochim Biophys Acta (1967) 0.96
Modulation of ecotropic murine retroviruses by N-linked glycosylation of the cell surface receptor/amino acid transporter. J Virol (1996) 0.96